
Comparability Considerations For mRNA Product Development
By Elaine Peters, Genentech Following the success of the COVID-19 vaccines, there has been an exponential growth in mRNA-based product development. These have moved from being almost exclusively vaccines to now encompassing many therapeutic applications …